JP2023527311A5 - - Google Patents

Info

Publication number
JP2023527311A5
JP2023527311A5 JP2022571187A JP2022571187A JP2023527311A5 JP 2023527311 A5 JP2023527311 A5 JP 2023527311A5 JP 2022571187 A JP2022571187 A JP 2022571187A JP 2022571187 A JP2022571187 A JP 2022571187A JP 2023527311 A5 JP2023527311 A5 JP 2023527311A5
Authority
JP
Japan
Prior art keywords
bispecific
individualized
cell
binding chain
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022571187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023527311A (ja
JP7753256B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/000340 external-priority patent/WO2021234453A1/en
Publication of JP2023527311A publication Critical patent/JP2023527311A/ja
Publication of JP2023527311A5 publication Critical patent/JP2023527311A5/ja
Application granted granted Critical
Publication of JP7753256B2 publication Critical patent/JP7753256B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022571187A 2020-05-20 2021-05-19 二重特異性個別化アプタマー Active JP7753256B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063027629P 2020-05-20 2020-05-20
US63/027,629 2020-05-20
US202063121079P 2020-12-03 2020-12-03
US63/121,079 2020-12-03
PCT/IB2021/000340 WO2021234453A1 (en) 2020-05-20 2021-05-19 Bispecific personalized aptamers

Publications (3)

Publication Number Publication Date
JP2023527311A JP2023527311A (ja) 2023-06-28
JP2023527311A5 true JP2023527311A5 (https=) 2024-05-28
JP7753256B2 JP7753256B2 (ja) 2025-10-14

Family

ID=76845262

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022571187A Active JP7753256B2 (ja) 2020-05-20 2021-05-19 二重特異性個別化アプタマー

Country Status (6)

Country Link
US (1) US20230193285A1 (https=)
EP (1) EP4153750A1 (https=)
JP (1) JP7753256B2 (https=)
CN (1) CN116419763A (https=)
IL (1) IL298347A (https=)
WO (1) WO2021234453A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7837345B2 (ja) 2020-12-03 2026-03-30 アーミューン リミテッド Tリンパ球結合アプタマー
US20250215380A1 (en) * 2023-12-31 2025-07-03 Trenchant BioSystems, Inc. Optimized geometric design of a cell processing cassette

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10100316B2 (en) * 2002-11-21 2018-10-16 Archemix Llc Aptamers comprising CPG motifs
JP2007525177A (ja) 2003-04-21 2007-09-06 アーケミックス コーポレイション 血小板由来増殖因子に対する安定化アプタマーおよび腫瘍治療剤としてのそれらの使用
WO2010060030A1 (en) * 2008-11-24 2010-05-27 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Tlr ligand-nucleic acid nanostructure as a novel immune modulatory agent and method of using the same
WO2010144295A1 (en) * 2009-06-09 2010-12-16 University Of Miami Aptamer-targeted costimulatory ligand aptamer
US11219635B2 (en) * 2016-02-19 2022-01-11 City Of Hope Bi-specific aptamer
WO2018144854A1 (en) * 2017-02-02 2018-08-09 Caris Science, Inc. Targeted oligonucleotides
CN107483987B (zh) 2017-06-30 2020-02-07 武汉斗鱼网络科技有限公司 一种视频流地址的鉴权方法及装置
WO2020065404A2 (en) * 2018-09-28 2020-04-02 Augmanity Nano Ltd Methods and compositions for selection of functional aptamers

Similar Documents

Publication Publication Date Title
AU2022204601B2 (en) Methods for enhancing efficacy of therapeutic immune cells
US10662427B2 (en) Compositions and methods for inhibiting gene expression of LPA
RU2744194C2 (ru) Иммунотерапия рака
EP2491123B1 (en) Single molecule nucleic acid nanoparticles
CN110914431B (zh) 经人工操纵的免疫细胞
JP4843177B2 (ja) 遺伝子の阻害剤またはサプレッサーおよびその遺伝子の発現産物に結合する分子を含有する混合物
CN113164507A (zh) 由多个寡核苷酸构成的通过与靶标的互补相互作用调控基因表达的多靶向核酸构建体
JP2023527311A5 (https=)
JP2024512608A5 (https=)
EP4362984A1 (en) Compositions and methods for treating cancers
JP7043114B2 (ja) 細胞を活性化させるための方法およびキット
JP7753256B2 (ja) 二重特異性個別化アプタマー
AU2022340804A1 (en) Compositions and methods for treating cancers
IL299855A (en) Inhibitors of line1 and uses thereof
EP3974531A1 (en) Asymmetric sirna inhibiting expression of pd-1
JP2023553193A5 (https=)
US11053503B2 (en) Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibition
JP7837345B2 (ja) Tリンパ球結合アプタマー
Chen et al. Synthetic immunity to break down the bottleneck of cancer immunotherapy
US20230285558A1 (en) Engineered t cells and tumor-infiltrating lymphocytes to increase tumor killing
WO2025079599A1 (ja) サブセットレベルで細胞を標的化可能な担体およびその製造方法
WO2026076302A1 (en) Novel method to generate "metabolically-fit" til for cancer immunotherapy
CN118159299A (zh) 用于治疗癌症的组合物和方法
CN117280033A (zh) T-淋巴细胞结合适体
HK40027138A (en) Artificially manipulated immune cell